Skip to main content
Bexsero 50 ug/.5mL, 50 ug/.5mL, 50 ug/.5mL, 25 ug/.5mL injection, suspension by GlaxoSmithKline Biologicals SA
Bexsero, 50 ug/.5mL, 50 ug/.5mL, 50 ug/.5mL, 25 ug/.5mL, injection, suspension Available on prescription only. Listed by GlaxoSmithKline Biologicals SA.
Prescription only

Bexsero

NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN

Listed by GlaxoSmithKline Biologicals SA

Strength
50 ug/.5mL, 50 ug/.5mL, 50 ug/.5mL, 25 ug/.5mL
Form
Injection, Suspension
Route
Intramuscular

What it contains

  • Neisseria Meningitidis Group B Nhba Fusion Protein Antigen 50 ug/.5mL
  • Neisseria Meningitidis Group B Fhbp Fusion Protein Antigen 50 ug/.5mL
  • Neisseria Meningitidis Group B Nada Protein Antigen 50 ug/.5mL
  • Neisseria Meningitidis Group B Strain Nz98/254 Outer Membrane Vesicle Antigen 25 ug/.5mL

This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.

FDA record

Dosage form Injection, Suspension
Route Intramuscular
Approval route BLA — biologic licence
NDC code 58160-976
FDA application BLA125546
Package sizes listed 1
Marketed since December 2016

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.